The new Medical Device Regulation (MDR) which becomes fully applicable on May 26, 2021 is initiated to improve patient safety, to increase transparency and traceability but also to bring EU legislation in line with technical advances and create a fair market access for manufacturers.
In the third session in our MDR seminar series, Dr Tina Amini walks you through the details of the impact of EU MDR on Drug/Device Combination Products (DDCs).